Global Research Antibodies & Reagents Market
Global Research Antibodies & Reagents Market Research 2024-2029 Featuring Prominent Players - Bio-Rad Laboratories, Bio-Techne, Danaher, F.Hoffmann La-Roche, Merck, and Thermo Fisher Scientific
April 10, 2024 07:04 ET | Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Research Antibodies & Reagents Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The...
22157.jpg
Global Research Antibodies Market Projected to Reach $5.5 Billion by 2030, Driven by Advances in Personalized Medicine
March 25, 2024 13:05 ET | Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Research Antibodies Market
Global Research Antibodies Analysis Report 2024: Emerging Opportunities with Expansion into Emerging Countries and Development of Novel Research Antibodies - Forecasts to 2028
January 17, 2024 04:23 ET | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Research Antibodies" report has been added to ResearchAndMarkets.com's offering. The global market for research antibodies was...
Vantage Market Research.png
Custom Antibody Market Size & Share to Surpass $1.2 Billion by 2030 | Vantage Market Research
July 28, 2023 03:32 ET | Vantage Market Research
WASHINGTON, July 28, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Custom Antibody Market has been steadily growing over the years due to the rising demand for individualized...
FINAL lOGO.png
Antibodies Contract Manufacturing Market Set to Reach US$17.5 Billion by 2033, Says Persistence Market Research
April 17, 2023 11:35 ET | Persistence Market Research
New York, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Antibodies Contract Manufacturing Market generated US$ 4.8 billion in revenue in 2022, and it is anticipated that this market will grow at a...
MicrosoftTeams-image (5).png
Custom Antibody Market Size to Cross USD 1 Bn by 2033 with CAGR of 8.2% | Transparency Market Research
March 22, 2023 05:30 ET | Transparency Market Research
Wilmington, Delaware, United States, March 22, 2023 (GLOBE NEWSWIRE) -- According to the newly released report by TMR, the global custom antibody market is expected to be valued at US$ 442.3 million...
factMR-logo.png
Antibody Fragments Market to Expand as Pharmaceutical Industry finds Massive Demand: Fact.MR Research
December 13, 2022 16:00 ET | FACT.MR
Rockville, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The antibody fragments market is currently worth USD 7.56 billion and is expected to grow at a CAGR of 5.9% during the forecast period. By 2032, the...
logo 600X600.png
Global Research Antibodies Market to surpass US$ 5,637.8 Million by 2030, Says Coherent Market Insights (CMI)
September 28, 2022 08:40 ET | CMI
Seattle, Sept. 28, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights’ analysis, the global research antibodies market is estimated to be valued at US$ 3,574.6 Mn in 2022 and expected to...
SAB_Logo.png
SAB Biotherapeutics Announces Appointment of Alexandra Kropotova, M.D., as Chief Medical Officer
June 06, 2022 08:30 ET | SAB Biotherapeutics, Inc.
SIOUX FALLS, S.D., June 06, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces...
SAB_Logo.png
SAB Biotherapeutics Announces Update to the Phase 3 NIH ACTIV-2 Trial Design Evaluating SAB-185 for Treatment of COVID-19
February 25, 2022 06:00 ET | SAB Biotherapeutics, Inc.
ACTIV-2 Phase 3 trial continuing as placebo-controlled study in Omicron variant COVID participants SIOUX FALLS, S.D., Feb. 25, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (SAB) (Nasdaq: SABS), a...